Toll Free: 1-888-928-9744
Published: Dec, 2017 | Pages:
101 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
This report studies the global Overactive Bladder Drug market, analyzes and researches the Overactive Bladder Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like • Astellas Pharma, Inc. (Japan) • Pfizer, Inc. (U.S.) • Teva Pharmaceutical Industries Limited (Israel) • Allergan, Plc (Ireland) • Medtronic plc (Ireland) • Mylan N.V. (U.S.) • Endo International plc (Ireland) • Hisamitsu Pharmaceutical Co., Inc. (Japan) • Sanofi (France) • Apotex, Inc. (Canada) • Cogentix Medical, Inc. (U.S.) • Aurobindo Pharma Limited (India) Market segment by Regions/Countries, this report covers • United States • EU • Japan • China • India • Southeast Asia Market segment by Type, the product can be split into • Anticholinergics • Solifenacin • Oxybutynin • Darifenacin • Fesoterodine • Tolterodine • Trospium • Others Market segment by Application, Overactive Bladder Drug can be split into • Idiopathic Bladder Overactivity • Neurogenic Bladder Overactivity If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents Global Overactive Bladder Drug Market Size, Status and Forecast 2022 1 Industry Overview of Overactive Bladder Drug 1.1 Overactive Bladder Drug Market Overview 1.1.1 Overactive Bladder Drug Product Scope 1.1.2 Market Status and Outlook 1.2 Global Overactive Bladder Drug Market Size and Analysis by Regions 1.2.1 United States 1.2.2 EU 1.2.3 Japan 1.2.4 China 1.2.5 India 1.2.6 Southeast Asia 1.3 Overactive Bladder Drug Market by Type 1.3.1 Anticholinergics 1.3.2 Solifenacin 1.3.3 Oxybutynin 1.3.4 Darifenacin 1.3.5 Fesoterodine 1.3.6 Tolterodine 1.3.7 Trospium 1.3.8 Others 1.4 Overactive Bladder Drug Market by End Users/Application 1.4.1 Idiopathic Bladder Overactivity 1.4.2 Neurogenic Bladder Overactivity 2 Global Overactive Bladder Drug Competition Analysis by Players 2.1 Overactive Bladder Drug Market Size (Value) by Players (2016 and 2017) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 Astellas Pharma, Inc. (Japan) 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Overactive Bladder Drug Revenue (Value) (2012-2017) 3.1.5 Recent Developments 3.2 Pfizer, Inc. (U.S.) 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Overactive Bladder Drug Revenue (Value) (2012-2017) 3.2.5 Recent Developments 3.3 Teva Pharmaceutical Industries Limited (Israel) 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Overactive Bladder Drug Revenue (Value) (2012-2017) 3.3.5 Recent Developments 3.4 Allergan, Plc (Ireland) 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Overactive Bladder Drug Revenue (Value) (2012-2017) 3.4.5 Recent Developments 3.5 Medtronic plc (Ireland) 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Overactive Bladder Drug Revenue (Value) (2012-2017) 3.5.5 Recent Developments 3.6 Mylan N.V. (U.S.) 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Overactive Bladder Drug Revenue (Value) (2012-2017) 3.6.5 Recent Developments 3.7 Endo International plc (Ireland) 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Overactive Bladder Drug Revenue (Value) (2012-2017) 3.7.5 Recent Developments 3.8 Hisamitsu Pharmaceutical Co., Inc. (Japan) 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Overactive Bladder Drug Revenue (Value) (2012-2017) 3.8.5 Recent Developments 3.9 Sanofi (France) 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Overactive Bladder Drug Revenue (Value) (2012-2017) 3.9.5 Recent Developments 3.10 Apotex, Inc. (Canada) 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Overactive Bladder Drug Revenue (Value) (2012-2017) 3.10.5 Recent Developments 3.11 Cogentix Medical, Inc. (U.S.) 3.12 Aurobindo Pharma Limited (India) 4 Global Overactive Bladder Drug Market Size by Type and Application (2012-2017) 4.1 Global Overactive Bladder Drug Market Size by Type (2012-2017) 4.2 Global Overactive Bladder Drug Market Size by Application (2012-2017) 4.3 Potential Application of Overactive Bladder Drug in Future 4.4 Top Consumer/End Users of Overactive Bladder Drug 5 United States Overactive Bladder Drug Development Status and Outlook 5.1 United States Overactive Bladder Drug Market Size (2012-2017) 5.2 United States Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017) 6 EU Overactive Bladder Drug Development Status and Outlook 6.1 EU Overactive Bladder Drug Market Size (2012-2017) 6.2 EU Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017) 7 Japan Overactive Bladder Drug Development Status and Outlook 7.1 Japan Overactive Bladder Drug Market Size (2012-2017) 7.2 Japan Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017) 8 China Overactive Bladder Drug Development Status and Outlook 8.1 China Overactive Bladder Drug Market Size (2012-2017) 8.2 China Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017) 9 India Overactive Bladder Drug Development Status and Outlook 9.1 India Overactive Bladder Drug Market Size (2012-2017) 9.2 India Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017) 10 Southeast Asia Overactive Bladder Drug Development Status and Outlook 10.1 Southeast Asia Overactive Bladder Drug Market Size (2012-2017) 10.2 Southeast Asia Overactive Bladder Drug Market Size and Market Share by Players (2016 and 2017) 11 Market Forecast by Regions, Type and Application (2017-2022) 11.1 Global Overactive Bladder Drug Market Size (Value) by Regions (2017-2022) 11.1.1 United States Overactive Bladder Drug Revenue and Growth Rate (2017-2022) 11.1.2 EU Overactive Bladder Drug Revenue and Growth Rate (2017-2022) 11.1.3 Japan Overactive Bladder Drug Revenue and Growth Rate (2017-2022) 11.1.4 China Overactive Bladder Drug Revenue and Growth Rate (2017-2022) 11.1.5 India Overactive Bladder Drug Revenue and Growth Rate (2017-2022) 11.1.6 Southeast Asia Overactive Bladder Drug Revenue and Growth Rate (2017-2022) 11.2 Global Overactive Bladder Drug Market Size (Value) by Type (2017-2022) 11.3 Global Overactive Bladder Drug Market Size by Application (2017-2022) 12 Overactive Bladder Drug Market Dynamics 12.1 Overactive Bladder Drug Market Opportunities 12.2 Overactive Bladder Drug Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Overactive Bladder Drug Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Overactive Bladder Drug Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source
List of Tables and Figures Figure Overactive Bladder Drug Product Scope Figure Global Overactive Bladder Drug Market Size (Million USD) (2012-2017) Table Global Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Global Overactive Bladder Drug Market Share by Regions in 2016 Figure United States Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure EU Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Japan Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure China Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure India Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Southeast Asia Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Figure Global Overactive Bladder Drug Market Share by Type in 2016 Figure Anticholinergics Market Size (Million USD) and Growth Rate (2012-2017) Figure Solifenacin Market Size (Million USD) and Growth Rate (2012-2017) Figure Oxybutynin Market Size (Million USD) and Growth Rate (2012-2017) Figure Darifenacin Market Size (Million USD) and Growth Rate (2012-2017) Figure Fesoterodine Market Size (Million USD) and Growth Rate (2012-2017) Figure Tolterodine Market Size (Million USD) and Growth Rate (2012-2017) Figure Trospium Market Size (Million USD) and Growth Rate (2012-2017) Figure Others Market Size (Million USD) and Growth Rate (2012-2017) Figure Global Overactive Bladder Drug Market Share by Application in 2016 Table Key Downstream Customer in Idiopathic Bladder Overactivity Figure Overactive Bladder Drug Market Size (Million USD) and Growth Rate in Idiopathic Bladder Overactivity (2012-2017) Table Key Downstream Customer in Neurogenic Bladder Overactivity Figure Overactive Bladder Drug Market Size (Million USD) and Growth Rate in Neurogenic Bladder Overactivity (2012-2017) Figure Overactive Bladder Drug Market Size (Million USD) and Growth Rate in Applications 3 (2012-2017) Table Overactive Bladder Drug Market Size (Million USD) by Players (2016 and 2017) Figure Overactive Bladder Drug Market Size Share by Players in 2016 Figure Overactive Bladder Drug Market Size Share by Players in 2017 Table Astellas Pharma, Inc. (Japan) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Astellas Pharma, Inc. (Japan) (2012-2017) Figure Astellas Pharma, Inc. (Japan) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Pfizer, Inc. (U.S.) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Pfizer, Inc. (U.S.) (2012-2017) Figure Pfizer, Inc. (U.S.) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Teva Pharmaceutical Industries Limited (Israel) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Teva Pharmaceutical Industries Limited (Israel) (2012-2017) Figure Teva Pharmaceutical Industries Limited (Israel) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Allergan, Plc (Ireland) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Allergan, Plc (Ireland) (2012-2017) Figure Allergan, Plc (Ireland) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Medtronic plc (Ireland) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Medtronic plc (Ireland) (2012-2017) Figure Medtronic plc (Ireland) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Mylan N.V. (U.S.) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Mylan N.V. (U.S.) (2012-2017) Figure Mylan N.V. (U.S.) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Endo International plc (Ireland) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Endo International plc (Ireland) (2012-2017) Figure Endo International plc (Ireland) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Hisamitsu Pharmaceutical Co., Inc. (Japan) (2012-2017) Figure Hisamitsu Pharmaceutical Co., Inc. (Japan) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Sanofi (France) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Sanofi (France) (2012-2017) Figure Sanofi (France) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Apotex, Inc. (Canada) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Apotex, Inc. (Canada) (2012-2017) Figure Apotex, Inc. (Canada) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Cogentix Medical, Inc. (U.S.) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Cogentix Medical, Inc. (U.S.) (2012-2017) Figure Cogentix Medical, Inc. (U.S.) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Aurobindo Pharma Limited (India) Basic Information List Table Overactive Bladder Drug Business Revenue (Million USD) of Aurobindo Pharma Limited (India) (2012-2017) Figure Aurobindo Pharma Limited (India) Overactive Bladder Drug Business Revenue Market Share in 2016 Table Global Overactive Bladder Drug Market Size (Million USD) by Type (2012-2017) Figure Global Overactive Bladder Drug Market Size Share by Type in 2012 Figure Global Overactive Bladder Drug Market Size Share by Type in 2013 Figure Global Overactive Bladder Drug Market Size Share by Type in 2014 Figure Global Overactive Bladder Drug Market Size Share by Type in 2015 Figure Global Overactive Bladder Drug Market Size Share by Type in 2016 Figure Global Overactive Bladder Drug Market Size Share by Type in 2017 Table Global Overactive Bladder Drug Market Size (Million USD) by Application (2012-2017) Figure Global Overactive Bladder Drug Market Size (Million USD) by Application in 2012 Figure Global Overactive Bladder Drug Market Size (Million USD) by Application in 2013 Figure Global Overactive Bladder Drug Market Size (Million USD) by Application in 2014 Figure Global Overactive Bladder Drug Market Size (Million USD) by Application in 2015 Figure Global Overactive Bladder Drug Market Size (Million USD) by Application in 2016 Figure Global Overactive Bladder Drug Market Size (Million USD) by Application in 2017 Table Top Consumer/End Users of Overactive Bladder Drug Figure United States Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table United States Overactive Bladder Drug Market Size (Million USD) by Players (2012-2017) Figure United States Overactive Bladder Drug Market Size Share by Players in 2016 Figure United States Overactive Bladder Drug Market Size Share by Players in 2017 Figure EU Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table EU Overactive Bladder Drug Market Size (Million USD) by Players (2012-2017) Figure EU Overactive Bladder Drug Market Size Share by Players in 2016 Figure EU Overactive Bladder Drug Market Size Share by Players in 2017 Figure Japan Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table Japan Overactive Bladder Drug Market Size (Million USD) by Players (2012-2017) Figure Japan Overactive Bladder Drug Market Size Share by Players in 2016 Figure Japan Overactive Bladder Drug Market Size Share by Players in 2017 Figure China Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table China Overactive Bladder Drug Market Size (Million USD) by Players (2012-2017) Figure China Overactive Bladder Drug Market Size Share by Players in 2016 Figure China Overactive Bladder Drug Market Size Share by Players in 2017 Figure India Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table India Overactive Bladder Drug Market Size (Million USD) by Players (2012-2017) Figure India Overactive Bladder Drug Market Size Share by Players in 2016 Figure India Overactive Bladder Drug Market Size Share by Players in 2017 Figure Southeast Asia Overactive Bladder Drug Market Size (Million USD) and Growth Rate by Regions (2012-2017) Table Southeast Asia Overactive Bladder Drug Market Size (Million USD) by Players (2012-2017) Figure Southeast Asia Overactive Bladder Drug Market Size Share by Players in 2016 Figure Southeast Asia Overactive Bladder Drug Market Size Share by Players in 2017 Figure Global Overactive Bladder Drug Market Size (Million USD) by Regions (2017-2022) Table Global Overactive Bladder Drug Market Size (Million USD) by Regions (2017-2022) Figure Global Overactive Bladder Drug Market Size Share by Regions in 2017 Figure Global Overactive Bladder Drug Market Size Share by Regions in 2022 Figure United States Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2017-2022) Figure EU Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2017-2022) Figure Japan Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2017-2022) Figure China Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2017-2022) Figure India Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2017-2022) Figure Southeast Asia Overactive Bladder Drug Revenue (Million USD) and Growth Rate (2017-2022) Table Global Overactive Bladder Drug Market Size (Million USD) by Type (2017-2022) Figure Global Overactive Bladder Drug Market Size Share by Type in 2017 Figure Global Overactive Bladder Drug Market Size Share by Type in 2022 Table Global Overactive Bladder Drug Market Size (Million USD) by Application (2017-2022) Figure Global Overactive Bladder Drug Market Size (Million USD) by Application in 2017 Figure Global Overactive Bladder Drug Market Size (Million USD) by Application in 2022
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.